LEAP THERAPEUTICS INC (LPTX) Stock Price, Quote, News and Overview
NASDAQ:LPTX - Nasdaq - US52187K2006 - Common Stock - Currency: USD
LPTX Quote, Performance and Key Statistics
LEAP THERAPEUTICS INC
NASDAQ:LPTX (1/30/2025, 11:13:01 AM)
0.56
-0.01 (-1.75%)
The current stock price of LPTX is 0.56 USD. In the past month the price decreased by -80.62%. In the past year, price decreased by -82.99%.
LPTX Latest News, Press Releases and Analysis
The trading volume of these stocks is deviating from the norm in today's session.
Let's have a look at what is happening on the US markets on Wednesday. Below you can find the stocks with an unusual volume in today's session.
Top movers analysis one hour before the close of the markets on 2025-01-28: top gainers and losers in today's session.
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
These stocks are moving in today's session
Let's have a look at what is happening on the US markets in the middle of the day on Tuesday. Below you can find the top gainers and losers in today's session.
The market is filled with gapping stocks in Tuesday's session.
The market is buzzing with gapping stocks on Tuesday. Let's uncover which stocks are experiencing notable gaps during today's session.
This Apple Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Leap Therapeutics Stock Plunges To Record Low After Ending Gastric Cancer Drug Trials, Retail Bets On CRC Pipeline
While sirexatamab combined with tislelizumab and chemotherapy showed some activity in biomarker-specific populations, the study failed to generate a clear positive signal on progression-free survival endpoints.
LPTX Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 16.31 | 309.87B | ||
| AMGN | AMGEN INC | 14.69 | 151.72B | ||
| GILD | GILEAD SCIENCES INC | 21.7 | 119.79B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 862.78 | 113.32B | ||
| REGN | REGENERON PHARMACEUTICALS | 14.94 | 74.59B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.49B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 35.48B | ||
| BNTX | BIONTECH SE-ADR | N/A | 29.27B | ||
| ONC | BEIGENE LTD-ADR | N/A | 24.38B | ||
| NTRA | NATERA INC | N/A | 22.79B | ||
| BIIB | BIOGEN INC | 9 | 21.42B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.24B |
Related stock screener links
About LPTX
Company Profile
Leap Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer. The company is headquartered in Cambridge, Massachusetts and currently employs 54 full-time employees. The company went IPO on 2017-01-24. The firm is focused on developing targeted and immuno-oncology therapeutics. Its advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-related protein 1 (DKK1) protein. DKK1 is also a modulator of CKAP4/PI3K/AKT signaling. DKN-01 is being developed in patients with esophagogastric, gynecologic, and colorectal cancers. Its second clinical-stage program is FL-301, a humanized monoclonal antibody targeting Claudin18.2, being developed in patients with gastric and pancreatic cancer. The company also has two preclinical antibody programs, FL-302 and FL-501. FL-302 is a Claudin18.2/CD137 (also known as 4-1BB) bispecific antibody that is in preclinical development. FL-501 is a monoclonal antibody in preclinical development that targets growth and differentiation factor 15 (GDF15), which is a cytokine that is produced at elevated levels in response to various stresses.
Company Info
LEAP THERAPEUTICS INC
47 Thorndike St Ste B1-1
Cambridge MASSACHUSETTS 02141 US
CEO: Douglas E. Onsi
Employees: 54
Company Website: https://www.leaptx.com/
Investor Relations: https://investors.leaptx.com/
Phone: 16172524343
LPTX FAQ
What is the stock price of LPTX?
The current stock price of LPTX is 0.56 USD.
What is the symbol for LEAP THERAPEUTICS INC stock?
The exchange symbol of LEAP THERAPEUTICS INC is LPTX and it is listed on the Nasdaq exchange.
On which exchange is LPTX stock listed?
LPTX stock is listed on the Nasdaq exchange.
Is LPTX a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for LPTX, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of LPTX.
Does LPTX stock pay dividends?
LPTX does not pay a dividend.
What is the Price/Earnings (PE) ratio of LPTX?
LPTX does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.93).
What is the Short Interest ratio of LPTX stock?
The outstanding short interest for LPTX is 6.91% of its float.
LPTX Technical Analysis
LPTX Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to LPTX. While LPTX seems to be doing ok healthwise, there are quite some concerns on its profitability.
LPTX Financial Highlights
Over the last trailing twelve months LPTX reported a non-GAAP Earnings per Share(EPS) of -1.93. The EPS decreased by 65.66% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -99.66% | ||
| ROE | -132.42% | ||
| Debt/Equity | 0 |
LPTX Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to LPTX. The Buy consensus is the average rating of analysts ratings from 9 analysts.